Abstract

BackgroundMalaria rapid diagnostics tests (RDTs) can increase availability of laboratory-based diagnosis and improve the overall management of febrile patients in malaria endemic areas. In preparation to scale-up RDTs in health facilities in Malawi, an evaluation of four RDTs to help guide national-level decision-making was conducted.MethodsA cross sectional study of four histidine rich-protein-type-2- (HRP2) based RDTs at four health centres in Blantyre, Malawi, was undertaken to evaluate the sensitivity and specificity of RDTs, assess prescriber adherence to RDT test results and explore operational issues regarding RDT implementation. Three RDTs were evaluated in only one health centre each and one RDT was evaluated in two health centres. Light microscopy in a reference laboratory was used as the gold standard.ResultsA total of 2,576 patients were included in the analysis. All of the RDTs tested had relatively high sensitivity for detecting any parasitaemia [Bioline SD (97%), First response malaria (92%), Paracheck (91%), ICT diagnostics (90%)], but low specificity [Bioline SD (39%), First response malaria (42%), Paracheck (68%), ICT diagnostics (54%)]. Specificity was significantly lower in patients who self-treated with an anti-malarial in the previous two weeks (odds ratio (OR) 0.5; p-value < 0.001), patients 5-15 years old versus patients > 15 years old (OR 0.4, p-value < 0.001) and when the RDT was performed by a community health worker versus a laboratory technician (OR 0.4; p-value < 0.001). Health workers correctly prescribed anti-malarials for patients with positive RDT results, but ignored negative RDT results with 58% of patients with a negative RDT result treated with an anti-malarial.ConclusionsThe results of this evaluation, combined with other published data and global recommendations, have been used to select RDTs for national scale-up. In addition, the study identified some key issues that need to be further delineated: the low field specificity of RDTs, variable RDT performance by different cadres of health workers and the need for a robust quality assurance system. Close monitoring of RDT scale-up will be needed to ensure that RDTs truly improve malaria case management.

Highlights

  • Malaria rapid diagnostics tests (RDTs) can increase availability of laboratory-based diagnosis and improve the overall management of febrile patients in malaria endemic areas

  • A total of 2,679 patients were recruited, but only 2,573 (96%) patients with complete RDT and expert microscopy results were included in the analysis

  • Demographic characteristics varied significantly between persons tested with the different RDTs (Table 1)

Read more

Summary

Introduction

Malaria rapid diagnostics tests (RDTs) can increase availability of laboratory-based diagnosis and improve the overall management of febrile patients in malaria endemic areas. Given the difficulty with implementing microscopy-based definitive diagnosis of malaria, malaria rapid diagnostic tests (RDTs) have been suggested as an alternative [6,7]. In line with WHO recommendations, the Malawi National Malaria Control Programme (NMCP) has developed new malaria treatment algorithms, which incorporate the use of RDTs for definitive diagnosis of malaria in patients aged ≥5 years who seek care in health facilities where malaria microscopy is not available. In preparation for nationwide implementation of RDTs, the NMCP reviewed the commercially available RDTs regarding their target antigen, sensitivity, specificity, shelf-life, heat stability, cost and reliability of suppliers to choose an RDT for national use. The study objectives were to assess field sensitivity and specificity, identify factors that might affect RDT field performance, assess prescriber adherence to RDT test results, and explore operational issues regarding RDT implementation

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call